As we move into 2025, it’s crucial for home health agencies to stay informed about the upcoming changes in the Interim Performance Reports (IPRs). These changes will impact how agencies review and utilize data to improve their services and outcomes. Below is an overview of what to expect on the upcoming releases of the Home Health Value-Based Purchasing (HHVBP) IPRs.

April Interim Performance Report

The April IPR will be a comprehensive report that includes the entire 2024-year OASIS outcomes data. This is a significant update, as it provides a full year’s worth of data for agencies to analyze and understand their performance. However, it’s important to note that this report will lag behind in claims and HHCAHPS data. Agencies should be prepared to review the OASIS outcomes thoroughly while awaiting the claims and HHCAHPS data in the next report.

July Interim Performance Report

The July IPR will be more complete, including the 2024 claims and HHCAHPS data. This report will provide agencies a more holistic view of their performance, combining outcomes, claims and patient satisfaction data. It’s an excellent opportunity for agencies to assess their overall performance and identify areas for improvement.

Reviewing Changes in OASIS and Claims Measures

Now is the perfect time to review the changes in OASIS and claims measures that were implemented on January 1. These changes are already impacting agencies and understanding them is key to navigating the upcoming reports. Preliminary numbers are available, reflecting the challenges agencies are facing with three new measures:

  1. Discharge Function: This measure assesses the functional status of patients at discharge, highlighting areas where agencies can improve patient care and support.
  2. Potentially Preventable Hospitalization: This measure focuses on hospitalizations that could have been avoided with better care, emphasizing the importance of proactive patient management.
  3. Discharge to Community: This measure tracks the percentage of patients discharged to their homes or community settings, without a subsequent hospitalization, underscoring the goal of reducing institutional care.

Expert Analysis and Solutions

McBee is here to help! Our team of HHVBP experts can analyze your results, review them with you and provide tailored solutions to address the challenges posed by these new measures. Don’t let 2025 pass you by. By staying informed and proactive, healthcare agencies can navigate these changes effectively and continue to provide high-quality care to their patients.

Schedule your FREE IPR review with McBee
Lisa Selman-Holman, JD, BSN, RN, HCS-D, COS-C Vice President, Education & Quality

About the Author

Lisa Selman-Holman, Vice President of Clinical Services

Lisa Selman-Holman, JD, BSN, RN, HCS-D, COS-C, is the VP of Clinical Services at McBee, bringing over 35 years of expertise in home health and hospice. As a registered nurse and home care attorney, she specializes in regulatory compliance. Lisa has held various roles, from field nurse to executive, managing accreditation surveys, acquisitions, and regulatory crises. In 2004, she founded Selman-Holman & Associates, offering consulting, coding and OASIS review services. Lisa is a renowned educator, known for turning challenges into achievements. Joining McBee in 2021, she leads education initiatives at the Post-Acute Academy, providing courses for home health and hospice staff and executives, including clinical, regulatory and onboarding requirements.

Never miss an update. Subscribe to our blog and get the top industry insights delivered right to your inbox.

SUBSCRIBE